XML 132 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
STOCKHOLDERS' EQUITY  
Schedule of common stock issued roll forward

 

Three Months Ended March 31,

2024

2023

Common stock:

Balance, beginning of quarter

183,606,708

171,656,030

Shares issued for stock options exercised

211,158

113,208

Agent growth incentive stock compensation

353,688

656,436

Agent equity stock compensation

2,189,922

2,106,369

Balance, end of quarter

186,361,476

174,532,043

Changes in the Company's stock compensation liability

Amount

Stock grant liability balance at December 31, 2022

$ 3,885

Stock grant liability increase year to date

3,832

Stock grants reclassified from liability to equity year to date

(2,717)

Balance, December 31, 2023

$ 5,000

Stock grant liability increase year to date

650

Stock grants reclassified from liability to equity year to date

-

Balance, March 31, 2024

$ 5,650

Schedule of shares repurchased

Three Months Ended March 31,

2024

2023

Treasury stock:

Balance, beginning of quarter

28,937,671

18,816,791

Repurchases of common stock

2,577,242

2,272,831

Balance, end of quarter

31,514,913

21,089,622